Title : The foundation for rare disease and its role in the european rare disease research landscape
Daniel Scherman, Foundation for Rare Diseases, France
The French rare disease research and clinical field has been a pioneer by structuring itself through different action plans. Competence centres and Reference centres are organized within Rare Disease Health Networks (Filières de Santé Maladies Rares), which ha [....] » Read More
Title : Precision pharmacotherapy in the treatment of epilepsy – use of antiseizure medications and therapeutic blood level monitoring?
Roy G Beran, University of New South Wales, Australia
This presentation will explore what happens to a Patient With Epilepsy (PWE) when (s) he attends the Emergency Department (ED) of the local teaching hospital which often includes the administration of an Antiseizure Medication (ASM) that is not the ASM that the patient was taking [....] » Read More
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model to be set up through biodesign-driven and inspired biotech, translational applications and upgraded business marketing to secure the human healthcare, wellness and biosafety
Sergey Suchkov, The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
A new and upgraded approach to the diseased states and wellness, and to re-shape tomorrow’s healthcare whilst doing it today, resulted in a new global trend in the healthcare services, namely, Personalized and Precision Medicine (PPM). PPM as a Unique Entity demonstrating a [....] » Read More